Immunotherapy improves survival of patients with locally advanced head and neck cancer: « Approved drug that revolutionized melanoma treatment may change standard of care for yet another cancer type

Psychosomatic Bias in Low-dose Radiation Epidemiology: Assessing the Role of Radiophobia and Stress in Cancer Incidence

Partnering olaparib with chemotherapy helps treat BRCA breast cancers

The impact of mutations on TP53 protein and MicroRNA expression in HNSCC: Novel insights for diagnostic and therapeutic strategies

GLP-1 receptor agonists show anti-cancer benefits beyond weight loss

A 20-cent 'wonder drug' is being studied as a colon-cancer-fighting supplement, and it looks promising

Cancer-Fighting Immune Cells Could Soon Be Engineered Inside Our Bodies

New study confirms the link between gas stoves and cancer risk: "Risks for the children are [approximately] 4-16 times higher"

Popular CT Scans Could Account for 5% of All Cancer Cases a Year

A recent study in Cell Systems sheds light on how skin cancer cells develop resistance to vemurafenib, a BRAF inhibitor that targets melanoma